In summary, our results suggest that targeting CysLT1R can prevent colon cancer initiation and/or progression, as demonstrated in a xenograft mouse model, primarily via reduction of tumor cell proliferation and induction of apoptosis. This evidence concerns the gene CYSLTR1 and neoplasm.